Treatment Response Monitoring and Subspecialty Referral for VMS

In "Treatment Response Monitoring and Subspecialty Referral for VMS," our panel explores the practical approach to safety monitoring and multidisciplinary co-management for a patient with VMS, well-controlled hypertension, prediabetes, and borderline lipids on menopause hormone therapy. The experts emphasize that while there is no rigid monitoring protocol, patients with cardiovascular risk factors warrant closer follow-up — including more frequent lipid checks and regular touchpoints in the first year of treatment — to ensure both safety and treatment response are adequately tracked. They stress the importance of keeping communication channels open between visits, whether through patient portal messaging or nurse check-ins, so that patients feel supported and empowered to report changes without waiting for a scheduled appointment.

The conversation then turns to the co-management of VMS across primary care, gynecology, cardiology, and endocrinology. The experts affirm that the appropriate threshold for involving additional subspecialties is highly individualized and depends on each clinician's comfort level with the complexity of findings on labs or testing. Rather than prescribing a rigid referral algorithm, they encourage clinicians to trust their clinical instincts — noting that the moment a provider begins to question whether they have fully addressed a patient's needs is precisely the moment to seek consultation or refer. The experts close by reiterating that heart disease remains the leading cause of death in women, making cardiovascular prevention a central pillar of menopause care and a compelling reason to build strong referral relationships with preventive cardiologists.

Our next episode, "A Case of a 51-Year-Old Woman with VMS and Inadequate Response to MHT," features two menopause experts discussing the clinical evaluation of a Hispanic woman with persistent VMS despite prior hormonal therapy trials, and exploring how to systematically assess treatment history, identify gaps in prior management, and develop a personalized combination approach using non-hormonal and lifestyle strategies.